{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06347016",
            "orgStudyIdInfo": {
                "id": "AROAPOC3-3004"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-509301-80",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Arrowhead Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of Plozasiran in Adults With Severe Hypertriglyceridemia",
            "officialTitle": "Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozsiran in Adults With Severe Hypertriglyceridemia",
            "acronym": "SHASTA-4",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-of-plozasiran-in-adults-with-severe-hypertriglyceridemia"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07-23",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-29",
            "studyFirstSubmitQcDate": "2024-03-29",
            "studyFirstPostDateStruct": {
                "date": "2024-04-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Arrowhead Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (SHTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozasiran or placebo, and be evaluated for efficacy and safety. After Month 12, eligible participants will be offered an opportunity to continue in an optional open-label extension under a separate protocol."
        },
        "conditionsModule": {
            "conditions": [
                "Severe Hypertriglyceridemia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 300,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Plozasiran Injection",
                    "type": "EXPERIMENTAL",
                    "description": "4 doses of plozasiran (ARO-APOC3) by subcutaneous (sc) injection",
                    "interventionNames": [
                        "Drug: Plozasiran Injection"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "calculated volume to match active treatment by sc injection",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Plozasiran Injection",
                    "description": "ARO-APOC3 Injection",
                    "armGroupLabels": [
                        "Plozasiran Injection"
                    ],
                    "otherNames": [
                        "ARO-APOC3"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "sterile normal saline (0.9% NaCl)",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percent Change in Fasting Serum Triglyceride (TG) Levels from Baseline to Month 12 Compared to Placebo",
                    "timeFrame": "Baseline, Month 12"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percent Change in Fasting Serum TG Levels from Baseline to Month 10 Compared to Placebo",
                    "timeFrame": "Baseline, Month 10"
                },
                {
                    "measure": "Proportion of Subjects Who Achieve Fasting TG Levels of < 500 mg/dL (<5.65 mmol/L) at Month 10 and Month 12",
                    "timeFrame": "Month 10, Month 12"
                },
                {
                    "measure": "Adjudicated Abdominal Clinical Event Rate (Including Emergency Room Visits or Hospitalizations for Abdominal Pain Attributed to Hypertriglyceridemia and Events of Documented Pancreatitis) During the Treatment Period Compared to Placebo at Month 12",
                    "timeFrame": "Month 12"
                },
                {
                    "measure": "Proportion of Subjects Who Achieve Fasting TG Levels of <150mg/dL (<1.69 mmol/L) at Month 10 and Month 12 Compared to Placebo",
                    "timeFrame": "Month 10, Month 12"
                },
                {
                    "measure": "Number of Subjects with Adverse Events (AEs) and Serious Adverse Events (SAEs) Over Time through Month 12 as Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Incidence Rates of New-Onset Diabetes Mellitus (NODM) Throughout the Course of Treatment",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Incidence Rates of Impaired Glucose Tolerance Throughout the Course of Treatment",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Incidence Rates of Worsening of Existing Diabetes Throughout the Course of Treatment",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Change from Baseline in Hemoglobin A1c (HbA1c) and Other Glycemic Control Parameters During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Change from Baseline in Fasting Blood Glucose During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Change from Baseline in C-Peptide During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Change from Baseline in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Change from Baseline in Treatment-Emergent Adverse Events (TEAEs) and Treatment-Related Adverse Events (TRAEs) Associated with Worsening Glycemic Control During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Initiation of New Medication for Hyperglycemia among Study Participants Not Known to Have Pre-existing Diabetes Mellitus During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Adjudicated Major Adverse Cardiovascular Events (MACE) Rates During the Treatment Period Compared to Placebo",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Incidence of Anti-drug Antibodies (ADA) to Plozasiran in Subjects Receiving Plozasiran Over Time Through Month 12",
                    "timeFrame": "From first dose of study drug through Month 12"
                },
                {
                    "measure": "Titers of Anti-drug Antibodies (ADA) to Plozasiran in Subjects Receiving Plozasiran Over Time Through Month 12",
                    "timeFrame": "From first dose of study drug through Month 12"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Established diagnosis of severe hypertriglyceridemia (SHTG) and prior documented evidence (medical history) of fasting TG levels of \u2265500 mg/dL (\u22655.65 mmol/L)\n* Mean fasting TG level \u2265500 mg/dL (\u22655.65 mmol/L) collected at 2 separate and consecutive visits at least 7 days apart and no more than 17 days apart during the screening period\n* Fasting low density lipoprotein-cholesterol (LDL-C) \u2264130 mg/dL (\u22643.37 mmol/L) at screening\n* Screening HbA1C \u22648.5%\n* Must be on standard of care lipid-lowering medications per local guidelines (unless documented as intolerant as determined by the Investigator)\n\nExclusion Criteria:\n\n* Use of any hepatocyte-targeted small interfering ribonucleic acid (siRNA) that targets lipids and/or triglycerides within 365 days before Day 1 (except inclisiran, which is permitted). Administration of investigational drug and inclisiran must be separated by at least 4 weeks\n* Use of any other hepatocyte-targeted siRNA or antisense oligonucleotide molecule within 60 days or within 5-half-lives before Day 1 based on plasma pharmacokinetics (PK), whichever is longer (except inclisiran, which is permitted)\n* Known diagnosis of familial chylomicronemia syndrome (FCS) (type 1 Hyperlipoproteinemia) by documentation of confirmed homozygote or double heterozygote for loss-of-function mutations in type 1- causing genes\n* Body mass index \\>45kg/m\\^2\n\nNote: Additional Inclusion/Exclusion criteria may apply per protocol",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Medical Monitor",
                    "role": "CONTACT",
                    "phone": "626-304-3400",
                    "email": "plozasiran@arrowheadpharma.com"
                }
            ],
            "locations": [
                {
                    "facility": "National Heart Institute",
                    "status": "RECRUITING",
                    "city": "Beverly Hills",
                    "state": "California",
                    "zip": "90211",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Norman Lepor",
                            "role": "CONTACT",
                            "phone": "310-289-5221",
                            "email": "abueno@nationalheartinstitute.org"
                        },
                        {
                            "name": "Norman Lepor, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.07362,
                        "lon": -118.40036
                    }
                },
                {
                    "facility": "Innovative Research of West Florida, Inc.",
                    "status": "RECRUITING",
                    "city": "Clearwater",
                    "state": "Florida",
                    "zip": "33756",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Miguel Trevino",
                            "role": "CONTACT",
                            "phone": "727-584-6368",
                            "phoneExt": "219",
                            "email": "alexm@innovativeresearchfl.com"
                        },
                        {
                            "name": "Miguel Trevino, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.96585,
                        "lon": -82.8001
                    }
                },
                {
                    "facility": "The South Bend Clinic LLC",
                    "status": "RECRUITING",
                    "city": "South Bend",
                    "state": "Indiana",
                    "zip": "46617",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Melany Alvey",
                            "role": "CONTACT",
                            "phone": "574-204-6192",
                            "email": "melany.alvey@avacare.com"
                        },
                        {
                            "name": "Rita Schmid, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.68338,
                        "lon": -86.25001
                    }
                },
                {
                    "facility": "Cotton-O'Neil Clinical Research Center, Stormont-Vail West",
                    "status": "RECRUITING",
                    "city": "Topeka",
                    "state": "Kansas",
                    "zip": "66606",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ann Meyer",
                            "role": "CONTACT",
                            "phone": "785-368-0746",
                            "email": "annmeyer@stormontvail.org"
                        },
                        {
                            "name": "Michael Cox, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.04833,
                        "lon": -95.67804
                    }
                },
                {
                    "facility": "Annapolis Internal Medicine",
                    "status": "RECRUITING",
                    "city": "Annapolis",
                    "state": "Maryland",
                    "zip": "21401",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Titus Abraham",
                            "role": "CONTACT",
                            "phone": "410-897-9841"
                        },
                        {
                            "name": "Titus Abraham, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.97845,
                        "lon": -76.49218
                    }
                },
                {
                    "facility": "Velocity Clinical Research",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Nebraska",
                    "zip": "68701",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Delilah Sierra",
                            "role": "CONTACT",
                            "phone": "402-371-0797",
                            "email": "dsierra@velocityclinical.com"
                        },
                        {
                            "name": "Charles Harper, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.02834,
                        "lon": -97.417
                    }
                },
                {
                    "facility": "Lynn Health Science Institute",
                    "status": "RECRUITING",
                    "city": "Oklahoma City",
                    "state": "Oklahoma",
                    "zip": "73112",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Destiny Heinzig-Cartwright",
                            "role": "CONTACT",
                            "phone": "405-602-3936",
                            "email": "dheinzig@lhsi.net"
                        },
                        {
                            "name": "Ryan Morgan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.46756,
                        "lon": -97.51643
                    }
                },
                {
                    "facility": "Tribe Clinical Research",
                    "status": "RECRUITING",
                    "city": "Greenville",
                    "state": "South Carolina",
                    "zip": "29607",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sharon Van Patton",
                            "role": "CONTACT",
                            "phone": "864-334-0141",
                            "email": "svanpatton@tribecr.com"
                        },
                        {
                            "name": "Ronald Mayfield, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.85262,
                        "lon": -82.39401
                    }
                },
                {
                    "facility": "Diabetes and Thyroid Center of Fort Worth",
                    "status": "RECRUITING",
                    "city": "Fort Worth",
                    "state": "Texas",
                    "zip": "76132",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "C. Padilla",
                            "role": "CONTACT",
                            "phone": "817-779-4478",
                            "email": "cpadilla@dtc-fw.com"
                        },
                        {
                            "name": "Chris Bajaj, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.72541,
                        "lon": -97.32085
                    }
                },
                {
                    "facility": "Juno Research LLC",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77040",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Estrella Rodriguez",
                            "role": "CONTACT",
                            "phone": "713-779-5494",
                            "email": "Estrella@junoresearch.us"
                        },
                        {
                            "name": "Damaris Vega, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Care and Cure Clinic",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77090",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Aijaz Hussain",
                            "role": "CONTACT",
                            "phone": "832-885-7723",
                            "email": "ahussain@springclinicalresearch.com"
                        },
                        {
                            "name": "Sushma Gorrela, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Spring Clinical Research",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77090",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "A. Hussain",
                            "role": "CONTACT",
                            "phone": "832-885-7723",
                            "email": "ahussain@springclinicalresearch.com"
                        },
                        {
                            "name": "Sushma Gorrela, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Crossroads Clinical Research",
                    "status": "RECRUITING",
                    "city": "Victoria",
                    "state": "Texas",
                    "zip": "77901",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Debbie Gerloff",
                            "role": "CONTACT",
                            "phone": "361-574-7800",
                            "email": "dgerloff@crossroadscr.net"
                        },
                        {
                            "name": "Richard Leggett, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.80527,
                        "lon": -97.0036
                    }
                },
                {
                    "facility": "Cope Family Medicine",
                    "status": "RECRUITING",
                    "city": "Bountiful",
                    "state": "Utah",
                    "zip": "84010",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Angel Caballero",
                            "role": "CONTACT",
                            "phone": "385-300-8101",
                            "email": "angelcaballero@cctresearch.com"
                        },
                        {
                            "name": "Bryce Peterson, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.88939,
                        "lon": -111.88077
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000015228",
                    "term": "Hypertriglyceridemia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006949",
                    "term": "Hyperlipidemias"
                },
                {
                    "id": "D000050171",
                    "term": "Dyslipidemias"
                },
                {
                    "id": "D000052439",
                    "term": "Lipid Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17932",
                    "name": "Hypertriglyceridemia",
                    "asFound": "Hypertriglyceridemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10000",
                    "name": "Hyperlipidemias",
                    "relevance": "LOW"
                },
                {
                    "id": "M10002",
                    "name": "Hyperlipoproteinemias",
                    "relevance": "LOW"
                },
                {
                    "id": "M26181",
                    "name": "Dyslipidemias",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27029",
                    "name": "Lipid Metabolism Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}